BNP Paribas Financial Markets’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$65 Sell
4
-1
-20% -$16 ﹤0.01% 4528
2025
Q1
$101 Hold
5
﹤0.01% 4419
2024
Q4
$120 Hold
5
﹤0.01% 4417
2024
Q3
$81 Hold
5
﹤0.01% 3341
2024
Q2
$135 Hold
5
﹤0.01% 3274
2024
Q1
$1.44K Hold
5
﹤0.01% 3162
2023
Q4
$1.14K Hold
5
﹤0.01% 3127
2023
Q3
$722 Hold
5
﹤0.01% 3085
2023
Q2
$837 Hold
5
﹤0.01% 3153
2023
Q1
$606 Hold
5
﹤0.01% 3078
2022
Q4
$1.46K Hold
5
﹤0.01% 3100
2022
Q3
$265 Hold
5
﹤0.01% 3871
2022
Q2
$288 Hold
5
﹤0.01% 3335
2022
Q1
$548 Hold
5
﹤0.01% 3438
2021
Q4
$693 Hold
5
﹤0.01% 3434
2021
Q3
$1.19K Hold
5
﹤0.01% 3253
2021
Q2
$1.26K Sell
5
-146
-97% -$36.7K ﹤0.01% 3326
2021
Q1
$45.4K Buy
151
+80
+113% +$24K ﹤0.01% 3069
2020
Q4
$26.5K Sell
71
-15
-17% -$5.61K ﹤0.01% 3131
2020
Q3
$26.3K Buy
86
+68
+378% +$20.8K ﹤0.01% 3114
2020
Q2
$6.87K Sell
18
-87
-83% -$33.2K ﹤0.01% 3245
2020
Q1
$23.9K Buy
105
+65
+163% +$14.8K ﹤0.01% 3245
2019
Q4
$20.9K Sell
40
-15
-27% -$7.85K ﹤0.01% 3322
2019
Q3
$23.5K Buy
55
+17
+45% +$7.26K ﹤0.01% 3239
2019
Q2
$45.4K Sell
38
-33
-46% -$39.4K ﹤0.01% 2865
2019
Q1
$88.3K Buy
+71
New +$88.3K ﹤0.01% 2614
2018
Q4
Sell
-11
Closed -$15.8K 3675
2018
Q3
$15.8K Hold
11
﹤0.01% 2849
2018
Q2
$17.7K Buy
+11
New +$17.7K ﹤0.01% 2900
2017
Q4
Sell
-1
Closed -$1.01K 3553
2017
Q3
$1.01K Hold
1
﹤0.01% 3453
2017
Q2
$804 Buy
+1
New +$804 ﹤0.01% 3494
2016
Q4
Sell
-8
Closed -$5.37K 3476
2016
Q3
$5.37K Buy
8
+4
+100% +$2.69K ﹤0.01% 3374
2016
Q2
$2.94K Buy
+4
New +$2.94K ﹤0.01% 3417
2014
Q4
Sell
-2
Closed -$1.3K 2300
2014
Q3
$1.3K Sell
2
-4
-67% -$2.6K ﹤0.01% 3437
2014
Q2
$4.97K Buy
+6
New +$4.97K ﹤0.01% 2125